Skip to main content
. 2019 Apr 26;2019(4):CD004055. doi: 10.1002/14651858.CD004055.pub2

34.12. Analysis.

34.12

Comparison 34 Oral retinoids: alitretinoin versus placebo, Outcome 12 Secondary: reduction in severity, investigatorā€rated in modified total lesion symptom score (bigger reduction in severity scored negative = better outcome).